ÂÜÀòÂÒÂ×

Tony Rush

Group Leader, Neuroscience and Translational Assays specialist at Metrion Biosciences

Tony has been an ion channel researcher for over 20 years across academia and industry and is widely published in the area. He received his Ph.D. from the University of Dundee (UK) characterising sodium channels of DRG neurons using the patch-clamp technique. He then studied hippocampal synaptic plasticity at Trinity College Dublin (Ireland) , before continuing sodium channel research with Stephen Waxman at Yale University (USA). Subsequently, Tony co-ordinated ion channel contracts at NeuroSolutions Ltd (UK), taking projects on multiple targets from initial discussions through to completion for a wide variety of clients in the biotechnology and pharmaceutical industries. He moved to AstraZeneca (Sweden) to work on preclinical pain targets where he was lead biologist for a number of ion channel programmes and large scale screens (IonWorks, QPatch, manual patch). Tony returned to the UK where he worked on ion channel screening projects (Patchliner) and translational neuroscience assays (MEA, manual patch) for external partners and grant-based projects firstly at Xention, and now at Metrion.

Links